- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about FULC
Recent news which mentions FULC
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 06, 2021
From Benzinga
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
Fulcrum Therapeutics's Return On Capital Employed Overview
September 22, 2021
Tickers
FULC
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
Cramer Weighs In On Lennar, Alibaba And More
September 15, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
August 23, 2021
From Benzinga
2 Soaring Biotech Stocks With More Fuel in the Tank
August 23, 2021
From Motley Fool
10 Biggest Price Target Changes For Tuesday
August 17, 2021
From Benzinga
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
August 15, 2021
From Benzinga
Analyzing Fulcrum Therapeutics's Unusual Options Activity
August 12, 2021
Tickers
FULC
From Benzinga
Mid-Afternoon Market Update: Dow Drops 50 Points; IEC Electronics Shares Spike Higher
August 12, 2021
From Benzinga
From Benzinga
66 Biggest Movers From Yesterday
August 12, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2021
August 11, 2021
From Benzinga
Why Are Fulcrum Therapeutics Shares Trading Higher Today?
August 11, 2021
Tickers
FULC
From Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 11, 2021
From Benzinga
85 Biggest Movers From Yesterday
August 11, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 10, 2021
From Benzinga
Tickers
FULC
From InvestorPlace
Mid-Afternoon Market Update: 3D Systems Surges On Upbeat Earnings; Katapult Shares Drop
August 10, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.